European Primary Care Cardiovascular Society


Consideration of BP lowering irrespective of prior CVD or baseline SBP

3' education - Sep. 30, 2020 - Kazem Rahimi, MD

Reduced blood pressure and incidence of hypertension with community-wide salt restriction

3' education - Sep. 16, 2019 - Paris, France - Prof. Jaime Miranda

Reduced CV risk with an intervention targeting identified barriers to care

3' education - Sep. 16, 2019 - Paris, France - Prof. J-D Schwalm
EPCCS Annual CV Summit

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs

ESC/ESH Guidelines on management of hypertension: what's new?

3' education - Feb. 11, 2019 - Prof. Bryan Williams - London, UK


3' education - Feb. 8, 2019

May Measurement Month: Get involved to increase awareness on elevated blood pressure

3' education - Feb. 6, 2019 - Prof. Neil Poulter - London, UK

The cardiovascular challenge for primary care in diabetes

10' education - July 10, 2018 - Prof. Richard Hobbs - Oxford, UK

Hypertension - Can we agree on diagnostic and therapeutic thresholds?

10' education - Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Prof. Richard McManus, prof. Richard Hobbs and prof. Christos Lionis

Pharmacist intervention in American 'black barbershops' effective at lowering BP

3' education - Mar. 12, 2018 - ACC 2018, Orlando, FL, USA - Dr. Ronald Victor, MD - Los Angeles, CA, USA

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

3' education - Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

3' education - Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS

What can be learned from the latest hypertension trials?

10' education - May 26, 2017

Identifying and treating patients with true hypertension

10' education - Feb. 24, 2016 - Prague - EPCCS 2015

Alcohol as a risk factor for hypertension

3' education - Nov. 20, 2014 - Brussels, Belgium - Prof. Daniel Duprez (Minnesota, USA) - EPCCS 2014

Renal denervation for truly resistant hypertension

3' education - Feb. 18, 2014 - London - 5-6 September 2013

What's new in hypertension guidelines?

3' education - Oct. 18, 2013 - EPCCS, September 5-6, 2013 - Richard McManus

What is the best method for diagnosing hypertension?

3' education - Sep. 7, 2012 - EPCCS 2012 - prof Richard McManus

Almost linear association between sodium intake and BP in persons with and without hypertension

Literature - Mar. 16, 2021 - Filippini T, et al. - Circulation. 2021

Sodium intake was almost linearly associated with SBP and DBP, without a threshold for low or high sodium exposure. The effect of sodium reduction on BP was more pronounced in individuals with hypertension.

Increased CVD risk associated with lower SBP range in women compared to men

Literature - Mar. 5, 2021 - Ji H et al. - Circulation. 2021.

This study used data from four community-based cohort studies and investigated the relation between SBP and incident CVD. Increasing CVD risk was observed beginning at lower SBP thresholds in women than in men.

The global burden of CVD and risk factors: An overview from 1990 to 2019

Literature - Jan. 22, 2021 - Roth GA, et al. - J Am Coll Cardiol. 2020

Global CVD burden has increased in almost all regions outside high-income countries. The increase was largely due to population growth and aging. In addition, attribution of risk factors like SBP, BMI, and dietary risk increased worldwide.

Identification of causal mechanism of age-related hypertension endotype

Literature - Dec. 10, 2020 - Elbatreek MH, et al. - PLoS Biol 2020

A study of network approaches with clinical and pre-clinical validation showed that NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism of an age-related hypertension endotype.

Increased risk of hypertension with moderate and heavy alcohol consumption

Literature - Sep. 30, 2020 - Mayl JJ et al. - J Am Heart Assoc. 2020

Compared to those who reported no alcohol intake, T2DM patients with moderate (>7 drinks/week) and heavy (>14 drinks/week) consumption had increased risk of elevated BP, hypertension grade I and hypertension grade 2.

Consideration of BP lowering irrespective of prior CVD or baseline SBP

3' education - Sep. 30, 2020 - Kazem Rahimi, MD
BP lowering  of 5 mm Hg results in 10% reduction of major CV events and is consistent whether individuals had a previous CVD or not, and is regardless of baseline SBP.

ESC 2020 A study including 48 RCTs demonstrated that lowering of each 5 mmHg SBP resulted in 10% reduction of major CV events, regardless of baseline SBP and CVD status.

Risk of major CV events reduced by BP lowering regardless of CVD status and baseline SBP

News - Sep. 9, 2020

ESC 2020 Blood pressure-lowering reduces the risk of major CV events similarly in those with and without CVD and irrespectively of baseline SBP.

Gradually increased risk of ASCVD with increasing SBP levels >90 mmHg

Literature - July 29, 2020 - Whelton SP et al. - JAMA Cardiol. 2020.

Presence of coronary artery calcium and risk of incident ASCVD events increased with increasing SBP levels in individuals with a SBP between 90 and 129 mmHg and no other traditional ASCVD risk factors.

Higher mortality risk in those with earlier onset of hypertension

Literature - July 14, 2020 - Wang C et al., - J Am Coll Cardiol. 2020.

In a case-control study of Chinese adults divided in age groups, earlier onset of hypertension was associated with higher risk of all-cause mortality and a trend for higher risk of CVD.

Reduction of antihypertensive medication noninferior to usual care in elderly

Literature - July 1, 2020 - Sheppard JP, et al. - JAMA 2020

Reduction of antihypertensive medication in patients ≥80 years who were on ≥2 antihypertensive medication was noninferior to usual care with regard to SBP control at 12 weeks.

Lowest risk of outcomes in HFpEF associated with SBP of 120-129 mmHg

Literature - May 28, 2020 - Selvaraj S et al., - J Am Coll Cardiol. 2020

This study showed that a SBP of 120 to 129 mmHg was associated with the lowest risk of adverse outcomes in HFpEF. SBP lowering does not explain the treatment effects of sacubitril/valsartan.

Continued ACEi and ARBs use in relation to coronavirus COVID-19 outbreak: an ESC statement

News - Mar. 16, 2020

The ESC Council on Hypertension has released a statement, strongly recommending to continue treatment of ACEi and ARBs in times of the COVID-19 pandemic, as evidence for harmful effects of these drugs in context of COVID-19 is lacking.